Aicure Inc., of New York, appointed Ed Ikeguchi president and Adam Hanina head of special projects.
Bavarian Nordic A/S, of Copenhagen, Denmark, appointed Laurence De Moerlooze executive vice president and chief medical officer.
Century Therapeutics Inc., of Philadelphia, appointed Joseph Jimenez to its board and Greg Russotti chief technology officer.
Decibel Therapeutics Inc., of Boston, appointed Laurence Reid acting CEO.
Disc Medicine Inc., of Cambridge, Mass., appointed John Quisel president and CEO.
Passage Bio, of Philadelphia, appointed Bruce Goldsmith CEO.
Pendulum Therapeutics Inc., of San Francisco, appointed Christopher E. Mason, Eric Schadt, Alfred Spormann, Dietrich Stephan, Peter Turnbaugh and Marion Leclerc to its scientific advisory board. It appointed John Buse, Ann L. Peters, Robert Ratner, Davida F. Kruger and Carol Wysham to its medical advisory board.
Verrica Pharmaceuticals Inc., of West Chester, Pa., appointed Gerard DiGirolamo vice president, sales, and Sheila Kennedy vice president, marketing.